[ad_1]
Breaking News E-mails
Receive last minute alerts and special reports. News and stories that matter, broadcast in the morning on weekdays.
By Dennis Romero
Denver's reputation at the kilometer level could get a boost after psychedelic drug advocates were given the go-ahead to urge voters to city to decriminalize magic mushrooms.
The Denver Psilocybin Mushroom Decriminalization Initiative will ask voters in May to approve an order that would make possession of the drug, whatever its weight, legal for those 21 years of age and older. They could also grow it. The bill, however, would not legalize retail sales, making the city an international player in the world of cannabis.
The Elections Division of the city stated that the organizers had submitted enough valid signatures to qualify for the May 7th municipal ballot. Kevin Matthews, director of the campaign, said it would be the first time that the decriminalization of psilocybin would be presented to US voters.
The campaign's long-term goal is to educate the public about the drug and put users behind bars.
"I do not anticipate a recreational cannabis model in the near future," he said.
The measure aims to put a stop to the criminal penalties applicable to the use and possession of psilocybin mushrooms. Its limitless component results from the nature of the mushrooms as a heavy and wet mushroom that is then dried, said Matthews. Proponents say that prosecutors do not always recognize the difference, but that law enforcement is changing.
"We are a pretty progressive city in drug policy," said Matthews, referring to the decriminalization of marijuana in the mid-2000s and to the state's legal recreational sales have started in 2014.
"Marijuana has somehow opened the door," he said.
Matthew W. Johnson, professor of psychiatry and behavioral science at the Johns Hopkins University School of Medicine, has studied psilocybin for potential use in the treatment of prostate cancer. anxiety and depression in cancer patients.
He stated in an interview with NBC News in June that the prospect of unhindered access to drugs was raising "real concerns about the very real risks of psychotic disorders – what people are referring to [19659007] "I personally see how intense these experiments can be," he said.
UCLA Professor of Psychiatry, Charles Grob, who also researched the drug, seemed to be in agreement [1965900] 7] "If, in fact, it is still available on a mass basis, it would be imperative to have a solid educational component so that people can understand what these compounds are ", he said in a separate interview in June." They should not be treated in a trivial way. "
Matthews says he's going forward with lucidity and that's why he's not going to be a good guy. He is planning a long-term education and research strategy. including a mayor committee with powers to review impacts.
"It's going to be a work in progress," he said
[ad_2]
Source link
